dpp4i and glp 1 The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect DPP-4 inhibitors and GLP-1RAs: cardiovascular

confirmed that the lower antioxidant enzyme activities might lead to oxidative stress through the oxidation of DNA and protein carbonyl content (general indicator marker of protein oxidation), which may affect the health status of FM patients [32]

ALT Aspartate transaminase (ALT) is an enzyme present in the liver that spills out during times of increased liver stress

In a randomized, placebo-controlled, double-blind trial, Labonia 272 treated 13 patients with L-carnitine 1 g IV after each dialysis session for 6 months and compared the results with 11 patients given a placebo control

ISSN 0882-7729

We prioritize urgent evaluations for patients on GLP-1 medications who develop new eye symptoms, especially those with known diabetic eye disease